DRUGS related term(s) Crime

Amendments

Office of National Drug Control Policy: reauthorize (H.R. 2829), H820, H821, H822, H824, H827, H828, H830, H832, H833, H834, H835, H837, H840, H841 [9MR]

———reauthorize (H.R. 2829), consideration (H. Res. 713), H800 [9MR]

Articles and editorials

Accutane Blamed in Suicide, H138 [1FE]

Coca Crop Jumps Despite U.S. Aid, E596 [25AP]

Colombia ``Most Dangerous'' Place for Trade Unionists, H3655 [9JN]

Colombia Says Soldiers Killed Antidrug Police—Authorities Probe Colonel for Link to Major Trafficker, H3655 [9JN]

Get Ready for Health Wars, E35 [31JA]

High Cost of Drug Caps, S7425 [12JY]

Soros Infiltrates Conservative Movement, E95 [8FE]

Bills and resolutions

Agriculture: prohibit open-air cultivation or use of human food or animal feed as host plant and establish tracking system to regulate genetically engineered pharmaceutical and industrial crops (see H.R. 5267), H1979 [2MY]

Children and youth: improve outcomes for children in families affected by methamphetamine abuse and addiction and reauthorize the Promoting Safe and Stable Families Program (see S. 3525), S5950 [15JN]

Dept. of HHS: establish a Biodefense Injury Compensation Program (see S. 2291), S1353 [15FE]

———improve residential treatment programs for pregnant and parenting women and programs to reduce substance abuse among nonviolent offenders (see S. 3055), S5226 [25MY] (see H.R. 5493), H3307 (see H.R. 5493), H3359 [25MY]

———require the incorporation of counterfeit-resistant technologies into the packaging of prescription drugs (see S. 2668), S3703 [27AP] (see H.R. 4829), H508 [1MR]

Dept. of Homeland Security: transfer to the Bureau of Immigration and Customs Enforcement all functions of the Customs Patrol Officers unit operating on the Tohono O'odham Indian reservation (see H.R. 5589), H3787 [12JN]

Dept. of Justice: develop a national strategy to eliminate illegal operations of certain international drug gangs (see H.R. 5291), H2173 [4MY]

Diseases: increase assistance to countries for the prevention, treatment, and control of tuberculosis (see S. 2465), S2467 [28MR] (see H.R. 5022), H1195 [28MR]

———promote research and development of drugs related to neglected and tropical diseases (see S. 2699), S3893 [2MY]

Drug abuse: reduce deaths occurring from overdoses of drugs or controlled substances (see S. 3557), S6419 [22JN]

Drug testing: prohibit the manufacture, marketing, sale, or shipment of products designed to assist in defrauding a drug test (see H.R. 4910), H790 [8MR]

FDA: anniversary (see H. Con. Res. 426), H3787 [12JN]

Federal Food, Drug, and Cosmetic Act: amend relative to distribution of the drug dextromethorphan (see H.R. 5280), H2101 [3MY]

———increase penalties relative to counterfeit drugs (see H.R. 5156), H1678 [6AP]

———require serious adverse event reporting for dietary supplements and nonprescription drugs (see S. 3546), S6283 [21JN]

Foreign countries: promote safe and ethical clinical trials of drugs and other test articles on people overseas (see H.R. 5641), H4327 [20JN]

Government regulations: impose requirements on Internet pharmacies, require manufacturers to implement chain-of-custody procedures, and restrict exemption on importation of controlled substances for personal use (see H.R. 4769), H387 [16FE]

———remove market exclusivity for certain drugs in order to enhance competition, improve access to generic drugs, and reduce consumer prices (see S. 2300), S1413 [16FE]

Health: permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests (see S. 2618), S3378 [7AP]

Health care providers: establish a volunteer corps to aid in dissemination and distribution of vaccines and other countermeasures during a public health emergency (see S. 3482), S5659 [8JN]

Immigration: prohibit the unauthorized construction of tunnels between the U.S. and another country (see H.R. 4816), H450 [28FE] (see H.R. 4830), H508 [1MR]

———prohibit unauthorized construction, financing, or reckless permitting (on one's land) the construction or use of a tunnel or subterranean passageway between the U.S. and another country (see S. 2355), S1644 [2MR] (see S. 2652), S3588 [26AP]

International AIDS Vaccine Initiative (nonprofit organization): anniversary (see H. Res. 844), H3308 (see H. Res. 844), H3361 [25MY]

Law enforcement officers: preserve and foster as one unit the Shadow Wolves located on Tohono O'odham lands (see H. Res. 829), H2962 [19MY]

Medicare: coverage of, as supplies for the injection of insulin, home needle destruction devices and the disposal of needles and lancets through a sharps-by-mail or similar program (see S. 3604), S6786 [29JN]

———deliver a meaningful benefit and lower prescription drug prices (see S. 2342), S1579 [1MR]

———eliminate months from calculation of any late enrollment penalty under the prescription drug program and provide additional funding for State health insurance counseling programs and area agencies on aging (see S. 2810), S4617 [16MY]

———eliminate prescription drug late enrollment penalty (see H.R. 5399), H2704 (see H.R. 5399), H2757 [17MY]

———encourage eligible beneficiaries who have not enrolled in the prescription drug benefit to review available options and determine whether enrolling best meets their prescription drug needs (see H. Res. 802), H2338 [9MY]

———ensure adequate payment amounts for drugs and biologicals (see H.R. 5179), H1741 [25AP]

———extend annual, coordinated election period under the prescription drug program and provide for a refund of excess premiums paid (see S. 2811), S4617 [16MY]

———extend annual coordinated election period for prescription drug plans (see H.R. 4715), H223 [8FE]

———extend eligibility period for ``Welcome to Medicare'' physical examination and eliminate coinsurance for screening mammography and colorectal cancer screening tests (see H.R. 5437), H2961 [19MY]

———extend employer subsidy payment provisions under the prescription drug program to State Pharmaceutical Assistance Programs (see S. 2344), S1579 [1MR] (see H.R. 4996), H1129 [16MR]

———extend enrollment period for prescription drug benefits and Medicare Advantage plans, negotiate fair prices for prescription drugs, and improve outreach and educational efforts with respect to such benefits (see H.R. 5297), H2173 [4MY]

———extend initial enrollment period for prescription drug benefits, waive penalties for late enrollment, allow prescription drug plan enrollment changes during the first year of enrollment, and limit drug formulary changes (see H.R. 5263), H1979 [2MY]

———extend initial enrollment period for prescription drug benefits, waive penalties for late enrollment, allow prescription drug plan enrollment changes once a year, and limit drug formulary changes (see H.R. 5116), H1677 [6AP]

———extend open enrollment period for prescription drug plans and eliminate penalties for late enrollment in such plans (see H.R. 4938), H867 [9MR]

———extend open enrollment period for prescription drug plans and Medicare Advantage-Prescription Drug plans (see H.R. 4723), H224 [8FE]

———extend open enrollment period for prescription drug plans and Medicare Advantage-Prescription Drug plans without any late enrollment penalty (see H.R. 5387), H2640 [16MY]

———improve access to pharmacies under part D (see S. 2664), S3703 [27AP]

———improve implementation of prescription drug program (see H.R. 4796), H388 [16FE]

———improve payments made by prescription drug plans and Medicare Advantage-Prescription Drug plans to pharmacies for covered drugs (see H.R. 5166), H1679 [6AP]

———include costs incurred by certain agencies, health centers, or drug assistance programs toward the out-of-pocket treshold of the prescription drug program (see S. 3650), S7415 [12JY]

———limit the penalty for late enrollment in the prescription drug program (see H.R. 5750), H4957 [10JY]

———permit beneficiaries enrolled in Medicare or Medicare Advantage prescription drug plans that change their formularies or increase prices to enroll in other plans (see S. 2313), S1414 [16FE]

———prohibit removal of covered drugs from prescription drug plan formularies during the plan year (see S. 2255), S864 [8FE] (see H.R. 5102), H1562 [5AP]

———provide a special enrollment period for enrollment under the prescription drug program (see H.R. 5596), H3907 [13JN]

———provide a special enrollment period for enrollment under the prescription drug program and waive the late enrollment penalty for low-income individuals who enroll during such period (see H.R. 5691), H4679 [27JN]

———provide for a Medicare Prescription Drug Ombudsman (see H.R. 5433), H2961 [19MY]

———provide for additional outreach and education and provide a special enrollment period for individuals who qualify for an income-related subsidy under the prescription drug program (see S. 2759), S4155 [8MY]

———provide for counting expenses for nonformulary drugs against the annual out-of-pocket threshold for costs for covered drugs (see H.R. 4928), H867 [9MR]

———provide for same treatment of all individuals who applied for low-income subsidies for enrollment and waiver of late enrollment penalties under the Medicare part D program (see H.R. 5629), H4134 [15JN]

———provide residents of long-term facilities with assistance relative to prescription drug coverage (see S. 2184), S123 [25JA]

———reduce coverage gap in prescription drug coverage through savings resulting from negotiation of prescription drug prices (see S. 2354), S1644 [2MR]

———reform the prescription drug program (see S. 2240), S510 [2FE] (see H.R. 4792), H388 [16FE]

———replace the prescription drug benefit with a revised and simplified program for all beneficiaries (see H.R. 4697), H154 [1FE]

———require prescription drug plans to provide enrollee notice of less expensive part D covered drugs that may be substituted for dispensed drugs (see H.R. 4743), H273 [14FE]

———require prompt payment to pharmacies, restrict pharmacy co-branding on prescription drug cards, and provide guidelines for Medication Therapy Management Services programs under prescription drug program (see S. 2563), S3211 [6AP]

———require the sponsor of a prescription drug plan or an organization offering a Medicare Advantage-Prescription Drug plan to promptly pay submitted claims (see S. 2723), S4050 [4MY] (see H.R. 5182), H1741 [25AP] (see H.R. 5307), H2174 [4MY]

———simplify and improve the prescription drug program (see S. 2665), S3703 [27AP]

———suspend prescription drug late enrollment penalty (see H.R. 5173), H1741 [25AP] (see H.R. 5336), H2501 [10MY]

———waive monthly beneficiary premium under prescription drug plan or Medicare Advantage-Prescription Drug plan during months in which an enrollee has a gap in coverage (see S. 3647), S7415 [12JY]

Medicare Prescription Drug, Improvement, and Modernization Act: repeal cost containment provisions (see H.R. 5518), H3307 (see H.R. 5518), H3360 [25MY]

Medicare/Medicaid: assure uninterupted access to necessary medicines under the prescription drug benefit (see S. 2238), S446 [1FE] (see H.R. 4685), H153 [1FE]

———dual eligible benefits continuity, off-label uses of certain prescription drugs and biological products, and determinations denying coverage and certain costs incurred by pharmacies (see H.R. 5193), H1741 [25AP]

———eliminate cost-sharing for certain dual eligible populations under the prescription drug benefit (see S. 2234), S446 [1FE] (see H.R. 4722), H224 [8FE]

———eliminate cost-sharing for dual eligible populations under the prescription drug benefit (see S. 2203), S211 [26JA]

———provide for continuity of coverage of prescription drugs under the prescription drug plans for full-benefit dual eligible individuals (see H.R. 4937), H867 [9MR]

———provide for necessary dual eligible beneficiary protections in order to ensure access to the prescription drug benefit program (see S. 2183), S19 [20JA] (see S. 2183), S123 [25JA] (see H.R. 4660), H23 [31JA]

———reduce cost-sharing for certain dual eligible populations under the prescription drug benefit (see S. 2409), S2122 [14MR]

———reimburse States for costs incurred by covering dual eligible populations under the Medicare prescription drug benefit plan (see S. 2181), S19 [20JA] (see S. 2181), S123 [25JA] (see H.R. 4663, 4665), H23 (see H.R. 4675), H24 [31JA] (see H.R. 4721), H223 [8FE]

Methamphetamine: establish a federally-supported education and awareness campaign for the prevention of methamphetamine use (see S. 2315), S1414 [16FE]

———provide for a comprehensive Federal response to problems relative to methamphetamine abuse (see H.R. 4763), H332 [15FE]

National Police Athletic League Youth Enrichment Act: revise and extend (see S. 2704), S3984 [3MY]

National security: prepare and strengthen biodefenses against deliberate, accidental, and natural outbreaks of illness (see S. 2564), S3211 [6AP] (see H.R. 5533), H3423 [6JN]

National Vigil for Lost Promise: designate (see S. Res. 462), S3984 [3MY] (see S. Res. 495), S5230 [25MY]

———support goals and ideals (see H. Con. Res. 422), H3424 [6JN]

Native Americans: clarify that Indian tribes are eligible to receive grants for confronting the use of methamphetamine (see S. 2552), S2901 [5AP] (see S. 2643), S3506 [25AP]

New Mexico: designate Sandoval, Valencia, and Torrance Counties as the new Southwest Border High Intensity Drug Trafficking Area (see S. 3565), S6492 [26JN]

Office of National Drug Control Policy: reauthorize (see S. 2560), S3211 [6AP]

———reauthorize (H.R. 2829), consideration (see H. Res. 713), H790 [8MR]

Patents: establish procedures for granting compulsory patent licenses for exporting patented pharmaceutical products to certain countries consistent with international commitments made by the U.S. (see S. 3175), S5229 [25MY]

Pharmaceuticals: enhance research and education in the areas of pharmaceutical and biotechnology science and engineering (see S. 2793), S4469 [11MY]

———expand human clinical trials qualifying for the orphan drug tax credit (see H.R. 5080), H1452 [4AP]

———prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market (see S. 3582), S6560 [27JN]

———provide for prices that are fair to the producer and the consumer (see H.R. 4850), H564 [2MR]

———require prescription drug manufacturers, packers, and distributors to disclose certain gifts provided in connection with promotional or marketing activities (see H.R. 4718), H223 [8FE]

Public Health Security and Bioterrorism Preparedness and Response Act: revise and extend (see S. 2792), S4469 [11MY]

Public Health Service Act: protection of human subjects in research (see H.R. 5578), H3723 [9JN]

Tariff: aerosol valves designed to deliver a metered dose (50 microliters) of a pressurized liquid pharmaceutical (see S. 2505), S2799 [4AP]

———chloral (see S. 2861), S4835 [19MY]

Taxation: add meningococcal vaccines to the list of taxable vaccines for purposes of the Vaccine Injury Compensation Trust Fund (see H.R. 5135), H1677 [6AP]

———add papillomavirus vaccines to the list of taxable vaccines for purposes of the Vaccine Injury Compensation Trust Fund (see H.R. 5495), H3307 (see H.R. 5495), H3359 [25MY]

———allow a credit for contributions to charities providing assistance for health insurance premiums and drug copayments to transition the uninsured and Medicaid patients into private insurance (see H.R. 5613), H4008 [14JN]

———deny deduction for certain gifts and benefits provided to physicians by prescription drug manufacturers (see H.R. 4706), H160 [7FE]

———modernize treatment of biomedical research corporations (see H.R. 5115), H1676 [6AP]

Venezuela: actively support strategies for ensuring secure airport facilities that meet international certifications to prevent trafficking of controlled substances, narcotics, and laundered money (see H. Con. Res. 400), H2585 [11MY]

Essays

Mill Run Elementary Drug Abuse Resistance Education (DARE) Program: Brandon Greer, E1011 [6JN], E1084 [8JN]

———Colin Ceresa, E1012 [6JN], E1084 [8JN]

———Emily Ready, E1012 [6JN], E1085 [8JN]

———Francesca Beller, E1011 [6JN], E1084 [8JN]

———Nick Carroll, E1012 [6JN], E1085 [8JN]

———Rachel T. Williams, E1012 [6JN], E1084 [8JN]

———T.J. Soroka, E1011 [6JN]

Excerpts

Dept. of HHS indemnification clause in contract with Chiron Corp., S3778 [1MY]

Dept. of HHS special product liability and indemnification clause in contract with Sanofi Pasteur Inc., S3778 [1MY]

Letters

Deny tax deduction for certain gifts and benefits provided to physicians by prescription drug manufacturers: Leana S. Wen and Christopher P. McCoy, American Medical Student Association Foundation, E77 [7FE]

Dept. of HHS participation in National Conference on Methamphetamine, HIV, and Hepatitis: Representative Souder, Committee on Government Reform (House), H829, H830 [9MR]

Investigation of the role of Alexander Strategy Group in the development of Deficit Reduction Act provisions dealing with pharmaceutical companies: Representative Waxman, Committee on Government Reform (House), H41 [1FE]

Lower Prices Reduced With Increased Competition and Efficient Development of Drugs (Lower PRICED Drugs) Act: Annette Guarisco, Coalition for a Competitive Pharmaceutical Market, S1422 [16FE]

———David P. Sloane, AARP, S1422 [16FE]

———Kathleen Jaeger, Generic Pharmaceutical Association, S1422 [16FE]

———Ken W. Cole, General Motors Corp., S1422 [16FE]

Northern Border Air Wing initiative: Michael Chertoff, Sec. of Homeland Security, S7406 [12JY]

———Senator Levin, S7406 [12JY]

Office of National Drug Control Policy reauthorization: Representative Hoekstra, Committee on Intelligence (House, Select), H809 [9MR]

———Representative McKeon, Committee on Education and the Workforce (House), H810 [9MR]

———Representative Sensenbrenner, Committee on the Judiciary (House), H810 [9MR]

———Representative Tom Davis, Committee on Government Reform (House), H810 [9MR]

Permit negotiation of fair prices for prescription drugs and use resulting savings for budget deficit reduction: David P. Sloane, AARP, S2020 [13MR]

Request for a compulsory license for cancer drug Avastin: Respresentative Kucinich, E535 [6AP]

Veterans health care funding: Dennis Cullinan, VFW, S2094 [14MR]

———several veterans organizations, S2081 [14MR]

Messages

National Drug Control Strategy: President Bush, S861 [8FE], H193 [8FE]

Remarks in House

Africa Malaria Day: observance, E650 [27AP]

Agriculture: prohibit open-air cultivation or use of human food or animal feed as host plant and establish tracking system to regulate genetically engineered pharmaceutical and industrial crops (H.R. 5267), E687 [2MY]

American Conservative Union: inclusion of two advocates for drug legalization on drug policy panel at Conservative Political Action Conference, E94 [8FE]

Armed Forces: limit increase in the cost of TRICARE health care services, H2361, H2365 [10MY], H2511, H2513, H2517, H2545 [11MY]

Ashburn, VA: tribute to Mill Run Elementary School Drug Abuse Resistance Education (DARE) graduates, E1011 [6JN], E1083 [8JN]

Asthma Awareness Day: observance, H1986 [3MY]

BIA: Lake Roosevelt Management Enforcement Fund funding, H2789 [18MY]

Bureau of Customs and Border Patrol: confiscation and destruction of reimported prescription drugs from Canada, H299 [15FE], H3289 [25MY]

Children and youth: create programs to halt the rising rate of violence among girls, H279 [15FE]

———value of mentoring programs, H1438 [4AP]

Cocaine: adjust penalties for powder cocaine and crack cocaine offenses, H797 [9MR]

Colombia: U.S. policy, E596 [25AP]

Congress: relationship with special interest groups, H301 [15FE]

Correctional institutions: reduce recidivism of prisoners through improved substance abuse treatment programs, H4635 [27JN]

Crime: encourage the President to convene an international conference to develop more effective means to deal with growing threat of methamphetamine and synthetic drug precursor chemicals, H821, H822 [9MR]

———prevent violent career criminals from being released from prison, H943 [14MR]

———respond to the illegal production, distribution, and use of methamphetamines, H422 [28FE], H591, H600 [7MR], H650 [8MR], H799, H803 [9MR], H1436 [4AP]

DEA: Afghanistan counternarcotics aerial surveillance funding, H1022 [15MR]

Democratic Party: national agenda, H4181-H4187 [16JN]

Dept. of Defense: DC-3 Marine Patrol Aircraft project funding, H3770, H3771 [12JN]

———refueling vessel funding to assist Coast Guard drug interdiction vessels, H1014 [15MR]

Dept. of Education: Safe and Drug-Free Schools and Communities State Grant Program funding, H163 [8FE]

Dept. of HHS: AIDS Drug Assistance Program funding, H3365 [6JN]

Dept. of Homeland Security: include additional considerations in the risk-based formula used in the Urban Areas Security Initiative Grant Program, H3368 [6JN], E1066 [8JN]

———Shadow Wolves border patrol program funding, H3322, H3323 [25MY]

———transfer to the Bureau of Immigration and Customs Enforcement all functions of the Customs Patrol Officers unit operating on the Tohono O'odham Indian reservation (H.R. 5589), H4928-H4930 [10JY], E1370, E1371 [11JY]

Dept. of Justice: Criminal Records Upgrade Program funding, H4644 [27JN]

———develop a national strategy to eliminate illegal operations of certain international drug gangs (H.R. 5291), H2313 [9MY]

———drug court programs funding, H4661 [27JN]

———Drug Endangered Children Program funding, H4725, H4726 [28JN]

———Edward Byrne Memorial Justice Assistance Grant Program (Byrne/JAG Grant Program) funding, H3646, H3647 [9JN], H4642-H4644, H4656 [27JN], E1103, E1105 [9JN], E1307 [28JN], E1334 [29JN]

———Edward Byrne Memorial Justice Assistance Grant Program (Byrne/JAG Grant Program) funding through reductions in Bureau of the Census funding, H4656-H4660 [27JN]

———Justice Assistance Grant Program funding, H240 [14FE], H421 [28FE]

———prohibit funding for State and local drug task forces that do not collect and make available data relative to the racial distribution of convictions, H4802-H4804 [29JN]

———prohibit funding to prevent certain States from implementing State laws authorizing use of medical marijuana, H4735-H4739 [28JN], E1334 [29JN]

———Tennessee Meth Educational Program funding, E1367 [11JY]

Dept. of State: Colombia drug interdiction aircraft assistance funding, H1017-H1019 [15MR]

———Emergency Refugee and Migration Assistance Fund funding through reductions in Andean Counterdrug Initiative funding for Colombia, H3653-H3662 [9JN], E1114 [12JN]

———provide assistance to Mexico to prevent the production of methamphetamine and prevent diversion of methamphetamine precursors for illicit use, H3652, H3653 [9JN]

Diseases: combat avian flu, increase local preparedness, and create a program to develop a vaccine, H4537-H4540 [26JN], H5042-H5044 [11JY]

———improve access to HIV/AIDS-related treatments and services in developing countries, H4203 [19JN]

———improve preparation for an influenza pandemic, including an avian influenza pandemic, H1984, H1988 [3MY], H3708 [9JN], E812 [12MY]

———provide assistance to countries to combat tuberculosis, H3690 [9JN]

Families USA (organization): study on Medicare prescription drug plans, E1254 [23JN], E1310 [28JN]

FDA: anniversary (H. Con. Res. 426), H4357-H4359 [21JN]

———Center for Veterinary Medicine animal antibiotic use study funding, H3093 [23MY]

———improve ability to ensure drug safety, H3077 [23MY]

———withdraw approved application for the drug known as RU-486 and review process by which the FDA approved such drug (H.R. 1079), H1136 [28MR]

Global Fund To Fight AIDS, Tuberculosis, and Malaria (organization): funding, H3526 [8JN]

Government regulations: establish certain restrictions on drugs containing isotretinoin, including the drug marketed as Accutane, H138 [1FE]

Health: improve patient safety and reduce incidence of medical errors, H793 [9MR]

———link between child vaccinations containing mercury and autism, H357 [16FE]

———national policy to provide health care and reform insurance procedures, H1382-H1387 [30MR]

———repeal comprehensive liability protection for manufacturers of avian flu pandemic vaccines and products, H1092, H1093 [16MR]

Higher Education Act: repeal provisions prohibiting persons convicted of prior drug offenses from receiving student financial assistance, H820, H821 [9MR]

Iraq: increase in narcotics traffic, H4943 [10JY]

Law enforcement: ensure adequate funding is provided for certain high intensity drug trafficking areas, H804 [9MR]

———local law enforcement funding, H809 [9MR]

Medicare: deliver a meaningful benefit and lower prescription drug prices (H.R. 752), E825 [12MY], E1254 [23JN], E1310 [28JN]

———encourage eligible beneficiaries who have not enrolled in the prescription drug benefit to review available options and determine whether enrolling best meets their prescription drug needs (H. Res. 802), H2472-H2480 [10MY], E801 [11MY], E825 [12MY], E916 [19MY]

———ensure Medicare providers give accurate and complete information to senior citizens regarding prescription drug coverage, H5095 [12JY]

———extend annual coordinated election period for prescription drug plans and eliminate prescription drug late enrollment penalty, H4965 [11JY]

———extend implementation of prescription drug program, H978, H979 [15MR], H1064, H1065, H1066, H1090-H1092 [16MR], H1133 [28MR], H1203, H1310, H1312 [29MR], H1628 [6AP], H1748 [26AP], H1873 [27AP], H1925 [2MY], H2186, H2187 [9MY], H2345, H2473-H2480 [10MY], H2507, H2559, H2581 [11MY], H2647, H2648 [17MY], E649 [27AP]

———extend initial enrollment period for prescription drug benefits, waive penalties for late enrollment, allow prescription drug plan enrollment changes during the first year, and limit drug formulary changes (H.R. 5263), H2763 [18MY], E825 [12MY]

———extend initial enrollment period for prescription drug benefits and waive penalties for late enrollment (H.R. 4399), H1713 [25AP]

———implementation of prescription drug program, H3800 [13JN], H4373 [21JN]

———negotiate for lower prices for prescription drugs, eliminate gap in coverage of prescription drug benefits, and promulgate regulations for the reimportation of prescription drugs, H147, H148 [1FE]

———permit negotiation of fair prices for, and allow the reimportation of, prescription drugs, H4333 [21JN]

———permit negotiation of fair prices for prescription drugs, H4967 [11JY]

———prescription drug benefit coverage, H473 [1MR], H600 [7MR], H794, H795, H848 [9MR], H979 [15MR], H1134, H1135, H1136 [28MR], H1202, H1301-H1307, H1314 [29MR], H1326, H1369 [30MR], H1400, H1401 [4AP], H1455, H1459 [5AP], H1664-H1670 [6AP], H1683, H1684, H1685 [25AP], H1830-H1836 [26AP], H1884 [27AP], H1926 [2MY], H2341, H2344, H2345, H2495-H2499 [10MY], H2644, H2646, H2647 [17MY], H3231 [25MY], H4223 [20JN], H4686, H4687 [28JN], H5032, H5033 [11JY], E303 [8MR]

———prohibit negotiation of prices for prescription drugs, H1883 [27AP]

———provide extended and additional protection to beneficiaries enrolled in prescription drug benefit plans (H.R. 3861), H1987 [3MY]

———reform the prescription drug program, H162 [8FE], H277, H278, H279, H300 [15FE], H436 [28FE], H468, H484 [1MR], H551 [2MR], H1164 [28MR], H1367 [30MR], H1425, H1428 [4AP], H1593 [6AP], H2644 [17MY]

———require the sponsor of a prescription drug plan or an organization offering a Medicare Advantage-Prescription Drug plan to promptly pay submitted claims (H.R. 5182), H1953 [2MY]

Medicare/Medicaid: assure uninterupted access to necessary medicines under the prescription drug benefit (H.R. 4685), E55, E57 [1FE]

Methamphetamine: provide for a comprehensive Federal response to problems relative to methamphetamine abuse (H.R. 4763), H1499 [5AP]

Mexico: decriminalization of possession of small quantities of certain drugs, H1925 [2MY], H1984 [3MY], H2106 [4MY]

———international narcotics control and law enforcement funding, H3683, H3684 [9JN]

Michigan: tribute to Southwest Michigan's Regional Methamphetamine Taskforces, H809 [9MR]

Minneapolis/St. Paul City Pages (publication): condemn for publishing article advocating methamphetamine use, H1830 [26AP]

Morality and ethics: national objectives priority assignments, H1435-H1439 [4AP]

National Methamphetamine Prevention Week: establish (H. Res. 556), H1495-H1500 [5AP]

National security: enhance border security, H2344 [10MY]

National Vigil for Lost Promise: support goals and ideals (H. Con. Res. 422), H3403 [6JN]

Office of National Drug Control Policy: commission reports and establish clearinghouse relative to methamphetamine epidemic, H824-H827 [9MR]

———conduct study of persons kidnapped, killed, and missing along the U.S.-Mexico border, H827 [9MR]

———conduct study on drug court programs that conduct hearings in non-traditional places, such as schools, H823 [9MR]

———consult with major national law enforcement organizations on drug control policy recommendations, H841-H843 [9MR]

———demonstration programs by local partnerships to coerce abstinence in chronic hard-drug users under community supervision through drug testing and sanctions, H808 [9MR]

———demonstration programs by local partnerships to shut down illicit drug market hot-spots by deterring drug dealers or altering the dynamic of drug sales, H808 [9MR]

———develop strategy to combat border tunnels used for drug trafficking and other purposes, H828 [9MR]

———High Intensity Drug Trafficking Areas Program funding, H3824, H3875 [13JN], E1193 [16JN]

———perform assessment of illicit drug and alcohol use by children, H832, H833 [9MR]

———provide program that advises States on establishing laws and policies to address alcohol and drug issues, H833, H834 [9MR]

———reauthorize (H.R. 2829), H802-H847 [9MR], E278 [2MR], E397 [16MR]

———reauthorize (H.R. 2829), consideration (H. Res. 713), H795-H802 [9MR]

———request the Institute of Medicine of the National Academies conduct study on iatrogenic addiction associated with oxycodone hydrochloride controlled-release tablets, H834, H835 [9MR]

———require a minimum percentage of national media campaign funds be spent on advertisements to reduce methamphetamine use and award grants for such advertisements, H838-H840 [9MR]

———require report on representation of tribal governments in High Intensity Drug Trafficking Areas Program, H840, H841 [9MR]

———submit comprehensive strategy that addresses the increased threat of methamphetamine, H831 [9MR]

———submit report on Dept. of HHS participation in National Conference on Methamphetamine, HIV, and Hepatitis, H829 [9MR]

———sunset reauthorization, H835-H837 [9MR]

Pharmacies: impact of Medicare prescription drug benefit implementation and of Medicaid pharmacy reimbursement cuts, H240 [14FE], H356 [16FE]

Republican Party: national agenda, H3134, H3135 [23MY]

Taxation: deny deduction for certain gifts and benefits provided to physicians by prescription drug manufacturers (H.R. 4706), E76 [7FE]

Texas: removal of carrizo cane along the Rio Grande to eliminate the concealing of illegal activities, H3288 [25MY]

Remarks in Senate

Armed Forces: prohibit increase in copayments for TRICARE prescription drug program, S5740 [13JN], S5837-S5840 [14JN]

Crime: respond to the illegal production, distribution, and use of methamphetamines, S1385 [16FE], S1512 [28FE], S1593, S1610, S1614, S1619 [2MR], S2084 [14MR], S2567, S2596 [30MR], S2889, S2890 [5AP], S3493 [25AP]

Dept. of Defense: Defense Health Program funding for force protection work and medical care at the Vaccine Health Care Centers, S6361 [22JN]

———detailing of helicopters for use by the DEA, S7280 [10JY]

———retain title to aircraft provided to foreign countries for counter-drug activities, S6391 [22JN]

Dept. of HHS: establish a Biodefense Injury Compensation Program (S. 2291), S1360 [15FE]

Dept. of Homeland Security: Advanced Technology Northern Border Security Pilot Program implementation, S5180 [25MY]

———Northern Border Air Wing initiative funding, S4018 [4MY], S7405-S7407 [12JY]

———prevent Bureau of Customs and Border Protection seizure of imported prescription drugs for personal use, S7295-S7302, S7304, S7305 [11JY]

Dept. of Justice: Community Oriented Policing Services (COPS) Hot Spots Program funding, S2083-S2085 [14MR]

———Justice Assistance Grant Program funding, S1994 [13MR], S2109-S2111 [14MR]

———juvenile justice funding, S2271 [16MR]

Diseases: combat avian flu, increase local preparedness, and create a program to develop a vaccine, S2226, S2227, S2231 [16MR]

———improve and secure an adequate supply of influenza vaccine (S. 1828), S5629-S5631 [8JN]

———improve preparation for an influenza pandemic, including an avian influenza pandemic, S969 [9FE]

———increase assistance to countries for the prevention, treatment, and control of tuberculosis (S. 2465), S2472 [28MR]

———pandemic influenza vaccine injury compensation funding, S3778, S3779 [1MY], S3942, S3948 [3MY]

———promote research and development of drugs related to neglected and tropical diseases (S. 2699), S3900 [2MY]

———provide assistance to countries to combat avian influenza, S1887 [8MR]

Drug abuse: reduce deaths occurring from overdoses of drugs or controlled substances (S. 3557), S6422 [22JN]

FDA: anniversary (H. Con. Res. 426), S7180, S7181 [29JN]

———condemn delay of decision on the approval of over-the-counter emergency contraceptives, S7181 [29JN]

Federal Food, Drug, and Cosmetic Act: require serious adverse event reporting for dietary supplements and nonprescription drugs (S. 3546), S6285-S6287 [21JN]

Global Fund To Fight AIDS, Tuberculosis, and Malaria (organization): funding, S2268, S2269 [16MR]

Government regulations: remove market exclusivity for certain drugs in order to enhance competition, improve access to generic drugs, and reduce consumer prices (S. 2300), S1420 [16FE]

Health: permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests (S. 2618), S3390 [7AP]

———provide liability protection to manufacturers of pandemic vaccines, S3778, S3779 [1MY]

Immigration: prohibit unauthorized construction, financing, or reckless permitting (on one's land) the construction or use of a tunnel or subterranean passageway between the U.S. and another country, S7317 [11JY]

———prohibit unauthorized construction, financing, or reckless permitting (on one's land) the construction or use of a tunnel or subterranean passageway between the U.S. and another country (S. 2355), S1646 [2MR]

Latin America: report on congressional delegation trip to Colombia, Peru, Brazil, and Dominican Republic, S3494-S3498 [25AP]

Linton, IN: tribute to Linton Police Dept., S9 [18JA]

Medicaid: funding, S723 [6FE]

Medicare: eliminate months from calculation of any late enrollment penalty under the prescription drug program and provide additional funding for State health insurance counseling programs and area agencies on aging (S. 2810), S4645 [16MY], S4725 [17MY]

———extend annual, coordinated election period under the prescription drug program and provide for a refund of excess premiums paid (S. 2811), unanimous-consent request, S4579, S4580 [16MY]

———extend implementation of prescription drug program, S2148-S2154, S2177, S2178 [15MR], S4176 [9MY], S4247-S4250, S4256, S4298, S4382 [10MY], S4427-S4430, S4434, S4447, S4451, S4454, S4455 [11MY], S4543 [15MY]

———extend initial enrollment period for prescription drug benefits, waive penalties for late enrollment, allow prescription drug plan enrollment changes during the first year, and limit drug formulary changes, S4568-S4570 [15MY]

———extend initial enrollment period for prescription drug benefits and provide other additional beneficiary protections, S422 [1FE]

———extend open enrollment period for prescription drug plans and eliminate penalties for late enrollment in such plans, S4325 [10MY]

———improve access to pharmacies under part D (S. 2664), S3710 [27AP]

———improve implementation of the prescription drug benefit, S482-S484, S490, S491 [2FE], S1086 [13FE]

———include costs incurred by certain agencies, health centers, or drug assistance programs toward the out-of-pocket treshold of the prescription drug program (S. 3650), S7424 [12JY]

———permit beneficiaries enrolled in Medicare or Medicare Advantage prescription drug plans that change their formularies or increase prices to enroll in other plans (S. 2313), S1526-S1528 [28FE]

———permit negotiation of fair prices for, and allow the reimportation of, prescription drugs, S4101 [5MY], S6470 [26JN]

———permit negotiation of fair prices for, and allow the reimportation of, prescription drugs (S. 239), S358 [31JA]

———permit negotiation of fair prices for prescription drugs, S4174, S4175, S4194 [9MY], S4249, S4256, S4298 [10MY]

———permit negotiation of fair prices for prescription drugs and use resulting savings for budget deficit reduction, S2020 [13MR], S2165-S2168, S2178, S2179 [15MR]

———prescription drug benefit coverage, S111 [25JA], S358 [31JA], S857-S859 [8FE], S1055 [10FE], S1493 [27FE], S1514 [28FE], S4190 [9MY]

———prohibit removal of covered drugs from prescription drug plan formularies during the plan year (S. 2255), S865, S866 [8FE]

———provide a prescription drug benefit program which is administered directly through Medicare, S2266 [16MR]

———provide extended and additional protection to beneficiaries enrolled in prescription drug benefit plans (S. 1841), S4123 [8MY], S4324 [10MY], S4543 [15MY]

———provide for additional outreach and education and provide a special enrollment period for individuals who qualify for an income-related subsidy under the prescription drug program (S. 2759), S4157 [8MY]

———reduce coverage gap in prescription drug coverage through savings resulting from negotiation of prescription drug prices (S. 2354), S1645 [2MR]

———reform the prescription drug program, S1340-S1342 [15FE]

———reform the prescription drug program (S. 2240), S512 [2FE]

———require prompt payment to pharmacies, restrict pharmacy co-branding on prescription drug cards, and provide guidelines for Medication Therapy Management Services programs under prescription drug program (S. 2563), S3220-S3222 [6AP]

———require the sponsor of a prescription drug plan or an organization offering a Medicare Advantage-Prescription Drug plan to promptly pay submitted claims (S. 2723), S4454 [11MY]

———simplify and improve the prescription drug program (S. 2665), S3710 [27AP]

———State health insurance assistance programs funding, S4456 [11MY]

———waive monthly beneficiary premium under prescription drug plan or Medicare Advantage-Prescription Drug plan during months in which an enrollee has a gap in coverage (S. 3647), S7421 [12JY]

Medicare/Medicaid: eliminate cost-sharing for dual eligible populations under the prescription drug benefit (S. 2203), S230 [26JA]

———funding, S1083-S1086 [13FE], S1137 [14FE]

———provide for necessary dual eligible beneficiary protections in order to ensure access to the prescription drug benefit program, S482-S485, S491 [2FE]

———reduce cost-sharing for certain dual eligible populations under the prescription drug benefit (S. 2409), S2124, S2125 [14MR]

———reimburse States for costs incurred by covering dual eligible populations under the Medicare prescription drug benefit plan (S. 2181), S23-S25 [20JA], S130, S131 [25JA]

Methamphetamine: establish a federally-supported education and awareness campaign for the prevention of methamphetamine use (S. 2315), S1433 [16FE]

National Methamphetamine Prevention Week: establish (S. Res. 313), S4567 [15MY]

National Police Athletic League Youth Enrichment Act: revise and extend (S. 2704), S3988 [3MY]

National Vigil for Lost Promise: designate (S. Res. 462), S3990 [3MY]

———designate (S. Res. 495), S5272 [25MY]

Native Americans: clarify that Indian tribes are eligible to receive grants for confronting the use of methamphetamine (S. 2552), S2914 [5AP]

———clarify that Indian tribes are eligible to receive grants for confronting the use of methamphetamine (S. 2643), S3508 [25AP]

New Mexico: designate Sandoval, Valencia, and Torrance Counties as the new Southwest Border High Intensity Drug Trafficking Area (S. 3565), S6493 [26JN]

Office of National Drug Control Policy: reauthorize (S. 2560), S3217 [6AP]

Patents: establish procedures for granting compulsory patent licenses for exporting patented pharmaceutical products to certain countries consistent with international commitments made by the U.S. (S. 3175), S5245-S5247 [25MY]

Pharmaceuticals: enhance research and education in the areas of pharmaceutical and biotechnology science and engineering (S. 2793), S4476 [11MY]

———importation of prescription drugs, S4194 [9MY]

———importation of prescription drugs (S. 334), S7301 [11JY]

———permit commercial importation of prescription drugs from Canada, S1514 [28FE]

———prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market (S. 3582), S6577-S6579 [27JN]

Public Health Security and Bioterrorism Preparedness and Response Act: revise and extend (S. 2792), S4476 [11MY]

Senate: legislative priorities, S1170 [14FE], S5626 [8JN]

Social Security: delay implementation of voluntary prescription drug benefit program, extend Medicare prescription drug discount card and transitional assistance programs, and Medicaid coverage of prescription drugs, S404 [1FE]

Veterans: expand and enhance health care, mental health, transition, and disability benefits, S6594 [28JN]

———expand and enhance health care, mental health, transition, and disability benefits (S. 13), S6526 [27JN]

———health care funding, S2075-S2083, S2094, S2095 [14MR]

Reports

Lobbying Disclosure Act Requirements: Alexander Strategy Group, H41-H44 [1FE]

Reports filed

Congressional Drug Control Budget and Policy Assessment—A Review of the 2007 National Drug Control Budget and 2006 National Drug Control Policy: Committee on Government Reform (House) (H. Rept. 109-434), H1740 [25AP]

Consideration of H.R. 2829, Office of National Drug Control Policy Reauthorization: Committee on Rules (House) (H. Res. 713) (H. Rept. 109-387), H790 [8MR]

FDA Anniversary: Committee on Energy and Commerce (House) (H. Res. 426) (H. Rept. 109-511), H4327 [20JN]

Improving Outcomes for Children Affected by Meth Act: Committee on Finance (Senate) (S. 3525), S5949 [15JN]

———Committee on Finance (Senate) (S. 3525) (S. Rept. 109-269), S6457 [23JN]

Office of National Drug Control Policy Reauthorization: Committee on Energy and Commerce (House) (H.R. 2829) (H. Rept. 109-315), H571 [6MR]

———Committee on the Judiciary (House) (H.R. 2829) (H. Rept. 109-315), H571 [6MR]

———Committee on the Judiciary (Senate) (S. 2560), S5226 [25MY]

Statements

Office of National Drug Control Policy Reauthorization: Senator Specter, S3218 [6AP]

Summaries

Genetically Engineered Pharmaceutical and Industrial Crop Safety Act (H.R. 5267), E688 [2MY]

Testimonies

Medicare Prescription Drug Benefit Coverage: Tobey Schule, S858 [8FE]

Texts of

H. Con. Res. 422, support goals and ideals of National Vigil for Lost Promise, H3403 [6JN]

H. Con. Res. 426, FDA anniversary, H4357 [21JN]

H. Res. 556, National Methamphetamine Prevention Week, H1495 [5AP]

H. Res. 713, consideration of H.R. 2829, Office of National Drug Control Policy reauthorization, H795 [9MR]

H. Res. 802, encourage eligible beneficiaries who have not enrolled in the Medicare prescription drug benefit to review available options and determine whether enrolling best meets their prescription drug needs, H2472 [10MY]

H.R. 2829, Office of National Drug Control Policy reauthorization, H811-H820 [9MR]

H.R. 5589, transfer to the Bureau of Immigration and Customs Enforcement all functions of the Customs Patrol Officers unit operating on the Tohono O'odham Indian reservation, H4928 [10JY]

S. 2181, Medicare State Reimbursement Act, S24 [20JA], S130 [25JA]

S. 2183, Requiring Emergency Pharmaceutical Access for Individual Relief (REPAIR) Act, S25-S27 [20JA], S132-S134 [25JA]

S. 2240, Medicare Part D Reform Act, S512 [2FE]

S. 2291, Responsible Public Readiness and Emergency Preparedness Act, S1361-S1363 [15FE]

S. 2300, Lower Prices Reduced With Increased Competition and Efficient Development of Drugs (Lower PRICED Drugs) Act, S1421 [16FE]

S. 2313, Medicare Drug Honest Pricing Act, S1432 [16FE]

S. 2354, Medicare Prescription Drug Gap Reduction Act, S1645 [2MR]

S. 2355, Border Tunnel Prevention Act, S1646 [2MR]

S. 2552, Indian Tribes Methamphetamine Reduction Grants Act, S2914 [5AP]

S. 2563, Pharmacist Access and Recognition in Medicare (PhARM) Act, S3220 [6AP]

S. 2564, Biodefense and Pandemic Vaccine and Drug Development Act, S3222-S3227 [6AP]

S. 2704, National Police Athletic League Youth Enrichment Act revision and extension, S3989 [3MY]

S. 2810, Medicare Late Enrollment Assistance Act, S4621 [16MY]

S. 3175, Life-Saving Medicines Export Act, S5247-S5252 [25MY]

S. 3557, Drug Overdose Reduction Act, S6422 [22JN]

S. 3565, designate Sandoval, Valencia, and Torrance Counties, NM, as the new Southwest Border High Intensity Drug Trafficking Area, S6494 [26JN]

S. 3582, Preserve Access to Affordable Generics Act, S6578 [27JN]

S. 3647, Prescription for Fairness Act, S7422 [12JY]

S. 3650, Helping Fill the Medicare Rx Gap Act, S7425 [12JY]

S. Res. 313, National Methamphetamine Prevention Week, S4567 [15MY]

S. Res. 462, National Vigil for Lost Promise, S3990 [3MY]

S. Res. 495, National Vigil for Lost Promise, S5259, S5272 [25MY]